title: [Anticoagulants and platelet aggregation inhibitors in urology].
abstract: Anticoagulants are widely used in the prevention of thromboembolic disease (particularly during the postoperative period) and in the curative treatment of deep vein thromboses. Two classes of anticoagulants are currently available: heparins (standard heparin, low molecular weight heparin) and coumarin anticoagulants. The choice of anticoagulant must take into account the clinical context (preventive or curative treatment), as well as the pharmacological and pharmacokinetic properties of the anticoagulant. This treatment requires laboratory monitoring adopted to the anticoagulant selected.
authors.affiliation: Service d'Hématologie Biologique, Hôpital Tenon, Paris, France.
authors.forename: E
authors.initials: E
authors.lastname: Verdy
mesh_terms: D000925:Anticoagulants / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D016903:Drug Monitoring; D006801:Humans; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D014572:Urology; D014812:Vitamin K / Q000037:antagonists & inhibitors*
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014812:Vitamin K